NEW YORK—GCI Health has appointed Robert Eakins as its Canadian leader. In this new position, Eakins will develop strategies and activities to address clients’ corporate and brand requirements.
In addition to working on Canadian-focused healthcare business, Eakins will also work on global and North American mandates and new business efforts to ensure clients benefit from local knowledge and strategic counsel.
Eakins was most recently at MS&L Canada where he was senior vice president and healthcare practice leader. In that role, he was responsible for the development of new business and providing senior strategic counsel on communications mandates, social media programs and public relations and public affairs campaigns for hospital and provincial formulary listings, Health Canada approvals and outcomes of Common Drug Review.
He has worked with clients including Sanofi-Aventis, Sanofi Pasteur, Bayer HealthCare (pharmaceuticals, consumer care and diabetes care), Janssen-Ortho, and GlaxoSmithKline.